176
Participants
Start Date
September 27, 2017
Primary Completion Date
February 15, 2019
Study Completion Date
February 28, 2019
Intact Breast Lesion Excision System (BLES)
Intact BLES is an automated, percutaneous biopsy device capable of delivering a surgical quality specimen for histological review of breast abnormalities. It is uniquely suited to maintain lesion architecture within the biopsy sample, providing an opportunity for pathological assessment and the potential avoidance of an open surgical procedure.
The Breast Center at Chesapeake Regional Healthcare, Chesapeake
Metro Surgical Associates Inc., Lithonia
Winship Cancer Institute-Emory St. Joseph's, Atlanta
Dalton Surgical Group, Dalton
Birmingham Breast Care, Birmingham
Nashville Breast Center, Nashville
Holyoke Medical Center, Holyoke
Lead Sponsor
Medtronic Surgical Technologies
INDUSTRY